These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9762390)

  • 1. Comment: hyponatremia with venlafaxine.
    Boyd IW
    Ann Pharmacother; 1998 Sep; 32(9):981-2. PubMed ID: 9762390
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyponatremia with venlafaxine.
    Masood GR; Karki SD; Patterson WR
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine and reversible blepharoedema.
    Reif A; Pfuhlmann B
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):413-4. PubMed ID: 12466039
    [No Abstract]   [Full Text] [Related]  

  • 4. Onset of confusion in the context of late-life depression.
    Mulsant BH
    J Psychiatry Neurosci; 2007 Mar; 32(2):152. PubMed ID: 17353943
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine-induced hyponatremia.
    Gupta AK; Saravay SM
    J Clin Psychopharmacol; 1997 Jun; 17(3):223-5. PubMed ID: 9169969
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
    Jung YE; Jun TY; Kim KS; Bahk WM
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):437-43. PubMed ID: 21726494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
    Kirby D; Harrigan S; Ames D
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):231-7. PubMed ID: 11921151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine-induced hair loss.
    Pitchot W; Ansseau M
    Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine: not yet first in the antidepressant class.
    Harv Ment Health Lett; 2003 Apr; 19(10):5-7. PubMed ID: 12711568
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 11. Venlafaxine-associated hypomania in unipolar depression.
    Chand PK; Kalyani GS; Murthy P
    Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
    [No Abstract]   [Full Text] [Related]  

  • 12. Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.
    Berilgen MS
    J Clin Psychopharmacol; 2010 Dec; 30(6):753-4. PubMed ID: 21057247
    [No Abstract]   [Full Text] [Related]  

  • 13. Benztropine in the treatment of venlafaxine-induced sweating.
    Garber A; Gregory RJ
    J Clin Psychiatry; 1997 Apr; 58(4):176-7. PubMed ID: 9164433
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine withdrawal reactions.
    Louie AK; Lannon RA; Kirsch MA; Lewis TB
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.
    Ezra DG; Storoni M; Whitefield LA
    Eye (Lond); 2006 Jan; 20(1):128-9. PubMed ID: 15746956
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    Bertolín-Guillén JM; Climent-Díaz B; Navarré-Gimeno A
    Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
    Heisler MA; Guidry JR; Arnecke B
    Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
    [No Abstract]   [Full Text] [Related]  

  • 19. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW; Zitzelsberger A; Klieser E
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR; Gormly LJ
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.